La olanzapina en el tratamiento de la esquizofrenia de inicio en la infancia
Descargas
Publicado
Cómo citar
Número
Sección
Palabras clave:
olanzapina, tratamientoResumen
La olanzapina es un potente antagonista 5-HT 2a/2c, dopaminérgico Dl, D2 y D4 con actividad anticolinérgica, que presenta un perfil cuya afinidad sobre los receptores es similar a la clozapina. S. Kumra, I.K. Jacobsen, (1998), han realizado un estudio piloto para examinar la eficacia de la olanzapina en la esquizofrenia de inicio en la infancia, cuando ésta aparecía como refractaria al tratamiento habitual.
Descargas
Citas
Beasley C, Tollestson G, Tran P, Salteries W, Sanger T, Hamilton S, (Olanzapine HGAD Study Group). Olanzapine versus placebo and haloperidol: acute phase results of de North American double-blind Olanzapine trial. Neuropsycho- pharmacol 1996;14:111-3. https://doi.org/10.1016/0893-133X(95)00069-P
Campbell M, Palig M. Subjective treatment Emergent Symptoms Scale (STESS). Psychofarmarcol Bull 1985;21:1063- 82. '
Jacobsen LK, Walker M, Edwards J, Chappell P, Woolston J. Clozapine in the treatment of a young adolescent with schizophrenia. J Am Acad Child Adolesc Psychiatry 1994; 33:645-50. https://doi.org/10.1097/00004583-199406000-00004
Kumra S, Frazier J, Jacobsen LK, et al. Chilhood-onset Schizoprenia: a double-blind clozapine-halopendol comparison. Arch Gen Psychiatry 1996;53:1090-7. https://doi.org/10.1001/archpsyc.1996.01830120020005
Kumra S, Jacobsen LK, Lenane M, Barbara MS, et al. Chilhood- onset Schizophrenia: An Open-Label Study of Olanzapine in Adolescents. J Am Acad Child Adolesc Psychiatry 1998; 37:(4). https://doi.org/10.1097/00004583-199804000-00015
Mozcs T, Toren P, Chernauzan N, et al. Cae study: clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:65-70. https://doi.org/10.1097/00004583-199401000-00010
Orvaschel H, Tabrizi M, Chambers W. Schedule for affective disorders and Schizoprenia for School-age children Epidemiologic Version (Kiddic-SADS-E). 3a ed. Fort Lauderdale, FL: Nova University; 1980.
Rapoport J, Connors C, Rearing N. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 1985;21:1077-9.
Rapoport JL, Gield J, Kumra S, et al. Chilhood onset Schizophrenia: progressive ventricular change during adolescence. Arch Gen Psychiatry 1997;54:897-903. https://doi.org/10.1001/archpsyc.1997.01830220013002
Reich W, Weiner Z. DICA-RC (DSM-lll-R Version), revised version, V-R. St. Louis: Washington University; 1988.
Remselimidt H, Schulz E, Martin M, An open trial of clozapine in thirty-six adolescents with schizophrenia, J Child Adolesc Psychopharmacol 1994;4:31-41. https://doi.org/10.1089/cap.1994.4.31
Simpson G, Angus JSW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212:9-11. https://doi.org/10.1111/j.1600-0447.1970.tb02066.x